Analyst Update

Less than a week after its most recent update on GW Pharmaceuticals plc (NASDAQ: GWPH), Cantor Fitzgerald lowered its price target for the stock Monday after the issuance of the company's 10-K report.  The Analyst Analyst Elemer Piros reiterated an Overweight on GW...